跳至主要内容
临床试验/CTRI/2018/07/015024
CTRI/2018/07/015024尚未招募2 期

Evaluation of the efficacy and safety of Spinacia oleracea extract tablets and formulation of Spinacia oleracea and Boswellia serrata extract tablets in knee osteoarthritis, Randomized placebo controlled clinical trial - SPINOA

Pharmanza Herbal Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. American College of Rheumatology (ACR)criteria
  • At least 1 of 3
  • A. Age >50 yrs
  • B. Stiffness < 30 mins
  • C. Crepitus
  • 2. Osteophytes
  • 3. Patient willing to comply with study procedures and requirements

排除标准

  • 1.Patients with congenital arthropathy, rheumatoid arthritis, active gout, other type of arthritis with/without inflammation e.g. septic , fibromyalgia or collagen vascular disease
  • 2.Patients with known history of coagulopathies
  • 3.Osteoarthritis of any other joint except knee
  • 4.Patients with history of major trauma or surgery in the knee joint
  • 5.Patients with uncontrolled diabetes and hypertension
  • 6.Body mass index (BMI) >40 kg/m2.
  • 7.Patients with any severe cardiac, renal and hepatic disease
  • 8.Pregnant and lactating women
  • 9.Patients who participated in any clinical trial within 30 days before enrolment into the study

研究者

相似试验